References
- Goldschmidt N, Or O, Klein M, . The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Ann Hematol 2011;90:165–171.
- Abel GA, Vanderplas A, Rodriguez MA, . High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leuk Lymphoma 2012;53: 1113–1116.
- Guppy AE, Tebbutt NC, Norman A, . The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin’s lymphoma. Leuk Lymphoma 2003;44:123–125.
- Zinzani PL, Stefoni V, Tani M, . Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 2009;27:1781–1787.
- El-Galaly T, Mylam KJ, Brown P, . PET/CT surveillance in patients with Hodgkin lymphoma in first remission is associated with low positive predictive value and high costs. Haematologica 2011 Dec 29. [Epub ahead of print]
- El-Galaly T, Prakash V, Christiansen I, . Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center. Leuk Lymphoma 2011;52:597–603.
- Lee AI, Zuckerman DS, van den Abbeele AD, . Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. Cancer 2010;116:3835–3842.
- Wille-Jorgensen P, Laurberg S, Pahlman L, . An interim analysis of recruitment to the COLOFOL trial. Colorectal Dis 2009;11: 756–758.